Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 11, 2013, Pages 2549-2557

  Iso, Tatsuya ^a   Maeda, Kazuhisa ^b,g   Hanaoka, Hirofumi ^a,h   Suga, Toshihiro ^a   Goto, Kosaku ^a   Syamsunarno, Mas Rizky A A ^a   Hishiki, Takako ^c,d   Nagahata, Yoshiko ^c,d   Matsui, Hiroki ^a   Arai, Masashi ^a   Yamaguchi, Aiko ^a   Abumrad, Nada A ^f   Sano, Motoaki ^c,d   Suematsu, Makoto ^e   Endo, Keigo ^a   Hotamisligil, Gökhan S ^b   Kurabayashi, Masahiko ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c Department of Biochemistry ^*  (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g OSAKA UNIVERSITY HOSPITAL   (Japan)

^h CHIBA UNIVERSITY   (Japan)

Author keywords

capillaries; endothelial cells; fatty acid binding proteins; fatty acids; glucose; metabolism

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; FATTY ACID; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 4; FATTY ACID BINDING PROTEIN 5; FLUORODEOXYGLUCOSE F 18; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; IOCANLIDIC ACID I 125; KETONE BODY; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY ENDOTHELIUM; CATABOLISM; DIET RESTRICTION; FATTY ACID TRANSPORT; GENETIC REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART DEVELOPMENT; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; LIPID BLOOD LEVEL; METABOLOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE;

CAPILLARIES; ENDOTHELIAL CELLS; FATTY ACID BINDING PROTEINS; FATTY ACIDS; GLUCOSE; METABOLISM;

ADENOSINE DIPHOSPHATE; ANIMALS; ENDOTHELIUM, VASCULAR; ENERGY METABOLISM; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FLUORODEOXYGLUCOSE F18; IODOBENZENES; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; MYOCARDIUM; NEOPLASM PROTEINS; PHOSPHOCREATINE; PHOSPHOFRUCTOKINASE-2;

EID: 84887127675     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.301588     Document Type: Article

References (29)

1. van der Vusse GJ. Albumin as fatty acid transporter. Drug Metab Pharmacokinet. 2009;24:300-307.
2. van der Vusse GJ, van Bilsen M, Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res. 2000;45:279-293.
3. Hagberg CE, Falkevall A, Wang X, Larsson E, Huusko J, Nilsson I, et al. Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature. 2010;464:917-921.
4. Goto K, Iso T, Hanaoka H, Yamaguchi A, Suga T, Hattori A, et al. Peroxisome proliferator-activated receptor-? in capillary endothelia promotes fatty acid uptake by heart during long-term fasting. J Am Heart Assoc. 2013;2:e004861.
5. Kanda T, Brown JD, Orasanu G, Vogel S, Gonzalez FJ, Sartoretto J, et al. PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice. J Clin Invest. 2009;119:110-124.
6. Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008;7:489-503.
7. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science. 1996;274:1377-1379.
8. Maeda K, Uysal KT, Makowski L, Görgün CZ, Atsumi G, Parker RA, et al. Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes. 2003;52:300-307.
9. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice defcient in apolipoprotein E against atherosclerosis. Nat Med. 2001;7:699-705.
10. Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, et al. Combined adipocyte-macrophage fatty acid-binding protein defciency improves metabolism, atherosclerosis, and survival in apolipoprotein E-defcient mice. Circulation. 2004;110:1492-1498.
11. Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, Uysal KT, et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 2005;1:107-119.
12. Elmasri H, Karaaslan C, Teper Y, Ghelf E, Weng M, Ince TA, et al. Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J. 2009;23:3865-3873.
13. Masouyé I, Hagens G, Van Kuppevelt TH, Madsen P, Saurat JH, Veerkamp JH, et al. Endothelial cells of the human microvasculature express epidermal fatty acid-binding protein. Circ Res. 1997;81:297-303.
14. Opie LH. Heart Physiology. Baltimore, MD: Lippincott Williams & Wilkins; 2004:306-354.
15. de Lange P, Moreno M, Silvestri E, Lombardi A, Goglia F, Lanni A. Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms. FASEB J. 2007;21:3431-3441.
16. Steinberg GR, Kemp BE. AMPK in Health and Disease. Physiol Rev. 2009;89:1025-1078.
17. Furuhashi M, Fucho R, Görgün CZ, Tuncman G, Cao H, Hotamisligil GS. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest. 2008;118:2640-2650.
18. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identifcation of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell. 2008;134:933-944.
19. Luptak I, Balschi JA, Xing Y, Leone TC, Kelly DP, Tian R. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization. Circulation. 2005;112:2339-2346.
20. Hajri T, Han XX, Bonen A, Abumrad NA. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest. 2002;109:1381-1389.
21. Schaap FG, Binas B, Danneberg H, van der Vusse GJ, Glatz JF. Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene. Circ Res. 1999;85:329-337.
22. Binas B, Danneberg H, McWhir J, Mullins L, Clark AJ. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J. 1999;13:805-812.
23. Augustus AS, Buchanan J, Park TS, Hirata K, Noh HL, Sun J, et al. Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J Biol Chem. 2006;281:8716-8723.
24. Marray RK. Harper's Illustrated Biochemistry. New York, NY: McGraw Hill Professional; 2009.
25. Fawcett DW. A Textbook of Histology. New York, NY: Chapman & Hall; 1994:368-409.
26. Bartelt A, Bruns OT, Reimer R, Hohenberg H, Ittrich H, Peldschus K, et al. Brown adipose tissue activity controls triglyceride clearance. Nat Med. 2011;17:200-205.
27. Bharadwaj KG, Hiyama Y, Hu Y, Huggins LA, Ramakrishnan R, Abumrad NA, et al. Chylomicron-and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor-and non-receptor-mediated fatty acid uptake. J Biol Chem. 2010;285:37976-37986.
28. Fielding CJ. Metabolism of cholesterol-rich chylomicroms. Mechanism of binding and uptake of cholesteryl esters by the vascular bed of the perfused rat heart. J Clin Invest. 1978;62:141-151.
29. Furuhashi M, Tuncman G, Görgün CZ, Makowski L, Atsumi G, Vaillancourt E, et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature. 2007;447:959-965.